Free Access
Editorial
Issue
Med Sci (Paris)
Volume 28, Number 10, Octobre 2012
Page(s) 801 - 803
Section Éditoriaux
DOI https://doi.org/10.1051/medsci/20122810002
Published online 12 October 2012
  1. Maehle AH, Prüll CR, Halliwell RF. The emergence of the drug receptor theory. Nat Rev Drug Discov 2002 ; 1 : 637–641. [CrossRef] [PubMed] [Google Scholar]
  2. Hill SJ. G-protein-coupled receptors: past, present and future. Br J Pharmacol 2006 ; 147 : S27–S37. [CrossRef] [PubMed] [Google Scholar]
  3. Lewontin R. La triple hélice. Paris : Seuil, 2003 : 154 p. [Google Scholar]
  4. Chidiac P, Hébert T, Dennis M, Bouvier M. Inverse agonist activity of β2-adrenergic antagonists. Mol Pharmacol 1994 ; 45 : 490–499. [PubMed] [Google Scholar]
  5. Bond RA, Bouvier M. Inverse agonists and G protein-coupled receptors. In : Leff P, ed. Receptor-based drug design, chap. 16. New York : Marcel Dekker Inc., 1998 : 363–377. [Google Scholar]
  6. Azzi M, Charest P, Angers S, et al. β-arrestin-dependent activation of MAPK pathway by β2-adrenergic receptor inverse agonists. Proc Natl Acad Sci USA 2003 ; 100 : 11406–11411. [CrossRef] [Google Scholar]
  7. Kenakin TP. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 2007 ; 28 : 407–415. [CrossRef] [PubMed] [Google Scholar]
  8. Galandrin S, Oligny-Longpré G, Bouvier M. The evasive nature of drug efficacy : implications for drug discovery. Trends Pharmacol Sci 2007 ; 28 : 423–430. [CrossRef] [PubMed] [Google Scholar]
  9. Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptors, ontogeny and function. Annu Rev Pharmacol Toxicol 2002 ; 42 : 409–435. [CrossRef] [PubMed] [Google Scholar]
  10. Smith NJ, Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 2010 ; 62 : 701–725. [CrossRef] [PubMed] [Google Scholar]
  11. Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000 ; 289 : 739–745. [CrossRef] [PubMed] [Google Scholar]
  12. Cherezov V, Rosenbaum DM, Hanson MA, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007 ; 318 : 1258–1265. [CrossRef] [PubMed] [Google Scholar]
  13. Rasmussen SG, Choi HJ, Rosenbaum DM, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007 ; 450 : 383–387. [CrossRef] [PubMed] [Google Scholar]
  14. Rosenbaum DM, Cherezov V, Hanson MA, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007 ; 318 : 1266–1273. [CrossRef] [PubMed] [Google Scholar]
  15. Onaran H.A, Costa T. Where have all the active receptor states gone? Nat Chem Biol 2012 ; 8 : 674–647. [CrossRef] [PubMed] [Google Scholar]
  16. Rasmussen SG, Choi HJ, Fung JJ, et al. Structure of a nanobody-stabilized active state of the beta2 adrenoceptor. Nature 2011 ; 469 : 175–180. [CrossRef] [PubMed] [Google Scholar]
  17. Rasmussen SG, DeVree BT, Zou Y, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011 ; 477 : 549–555. [CrossRef] [PubMed] [Google Scholar]
  18. Wu B, Chien EY, Mol CD, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010 ; 330 : 1066–1071. [CrossRef] [PubMed] [Google Scholar]
  19. Manglik A, Kruse AC, Kobilka TS. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012 ; 485 : 321–326. [CrossRef] [PubMed] [Google Scholar]
  20. Wu H, Wacker D, Mileni M, et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012 ; 485 : 327–332. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.